News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,692 Results
Type
Article (81798)
Company Profile (482)
Press Release (763391)
Multimedia
Podcasts (209)
Webinars (32)
Section
Business (224927)
Career Advice (3450)
Deals (38905)
Drug Delivery (176)
Drug Development (90220)
Employer Resources (197)
FDA (18130)
Job Trends (16965)
News (384819)
Policy (38186)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3043)
Academic (1)
Accelerated approval (56)
Adcomms (40)
Allergies (191)
Alliances (54979)
ALS (234)
Alzheimer's disease (1959)
Antibody-drug conjugate (ADC) (543)
Approvals (18461)
Artificial intelligence (789)
Autoimmune disease (346)
Automation (62)
Bankruptcy (399)
Best Places to Work (12561)
BIOSECURE Act (22)
Biosimilars (247)
Biotechnology (308)
Bladder cancer (209)
Brain cancer (83)
Breast cancer (831)
Cancer (6471)
Cardiovascular disease (547)
Career advice (2962)
Career pathing (52)
CAR-T (379)
CDC (75)
Celiac Disease (3)
Cell therapy (1028)
Cervical cancer (53)
Clinical research (77726)
Collaboration (2321)
Company closure (7)
Compensation (1494)
Complete response letters (104)
COVID-19 (3037)
CRISPR (123)
C-suite (1263)
Cystic fibrosis (163)
Data (8560)
Decentralized trials (3)
Denatured (70)
Depression (191)
Dermatology (96)
Diabetes (658)
Diagnostics (7506)
Digital health (64)
Diversity (14)
Diversity, equity & inclusion (47)
Drug discovery (369)
Drug pricing (243)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (98281)
Editorial (78)
Employer branding (25)
Employer resources (169)
Events (133123)
Executive appointments (1185)
FDA (22132)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1904)
Gene editing (267)
Generative AI (72)
Gene therapy (825)
GLP-1 (1256)
Government (5474)
Grass and pollen (8)
Guidances (419)
Healthcare (21140)
HIV (90)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (350)
Immuno-oncology (114)
Indications (201)
Infectious disease (3427)
Inflammatory bowel disease (241)
Inflation Reduction Act (16)
Influenza (146)
Intellectual property (314)
Interviews (646)
IPO (17750)
IRA (60)
Job creations (4740)
Job search strategy (2400)
JPM (72)
Kidney cancer (22)
Labor market (114)
Layoffs (679)
Leadership (53)
Legal (9560)
Liver cancer (110)
Longevity (35)
Lung cancer (866)
Lymphoma (460)
Machine learning (63)
Management (64)
Manufacturing (1179)
MASH (221)
Medical device (15219)
Medtech (15368)
Mergers & acquisitions (22440)
Metabolic disorders (1749)
mRNA (260)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (492)
Neuropsychiatric disorders (125)
Neuroscience (3668)
Neurotech (2)
NextGen: Class of 2026 (7540)
Non-profit (5129)
Now hiring (80)
Obesity (840)
Opinion (372)
Ovarian cancer (242)
Pain (280)
Pancreatic cancer (342)
Parkinson's disease (410)
Partnered (38)
Patents (641)
Patient recruitment (734)
Peanut (69)
People (66030)
Pharmaceutical (92)
Pharmacy benefit managers (37)
Phase 1 (24027)
Phase 2 (33851)
Phase 3 (25441)
Pipeline (9581)
Policy (389)
Postmarket research (3391)
Preclinical (10710)
Press Release (72)
Prostate cancer (339)
Psychedelics (68)
Radiopharmaceuticals (367)
Rare diseases (1239)
Real estate (7020)
Recruiting (79)
Regulatory (29176)
Reports (65)
Research institute (2747)
Resumes & cover letters (548)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (194)
Series A (324)
Series B (232)
Service/supplier (17)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4264)
State (2)
Stomach cancer (21)
Supply chain (142)
Tariffs (104)
The Weekly (136)
Vaccines (1288)
Venture capital (130)
Weight loss (576)
Women's health (137)
Worklife (24)
Date
Today (83)
Last 7 days (768)
Last 30 days (3421)
Last 365 days (32290)
2026 (15325)
2025 (32241)
2024 (37507)
2023 (42449)
2022 (53784)
2021 (58555)
2020 (57497)
2019 (51095)
2018 (38886)
2017 (36470)
2016 (37023)
2015 (42859)
2014 (37298)
2013 (34660)
2012 (36198)
2011 (36235)
2010 (35731)
Location
Africa (1148)
Alabama (96)
Alaska (7)
Arizona (387)
Arkansas (16)
Asia (49079)
Australia (8520)
California (14141)
Canada (3942)
China (1541)
Colorado (605)
Connecticut (630)
Delaware (434)
Europe (112874)
Florida (2112)
Georgia (460)
Hawaii (4)
Idaho (69)
Illinois (1198)
India (99)
Indiana (654)
Iowa (24)
Japan (580)
Kansas (141)
Kentucky (54)
Louisiana (49)
Maine (83)
Maryland (1717)
Massachusetts (10305)
Michigan (391)
Minnesota (786)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (29)
Nevada (152)
New Hampshire (91)
New Jersey (3738)
New Mexico (34)
New York (3737)
North Carolina (1897)
North Dakota (11)
Northern California (7067)
Ohio (434)
Oklahoma (26)
Oregon (48)
Pennsylvania (2805)
Puerto Rico (30)
Rhode Island (54)
South America (1520)
South Carolina (88)
South Dakota (2)
Southern California (5581)
Tennessee (224)
Texas (2281)
United States (50459)
Utah (423)
Vermont (1)
Virginia (354)
Washington D.C. (89)
Washington State (1153)
West Virginia (4)
Wisconsin (145)
Wyoming (2)
845,692 Results for "st jude medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Carsten Bönnemann, MD, joins St. Jude to expand research on pediatric catastrophic neurological disorders
March 13, 2026
·
4 min read
Press Releases
St. Jude Children’s Research Hospital and ALSAC Announce New Board Members
November 20, 2025
·
6 min read
Press Releases
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
May 18, 2026
·
3 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Expands AI Commercialization Strategy with Enterprise Vision Solutions
May 11, 2026
·
2 min read
Press Releases
St. David’s South Austin Medical Center first in world to enroll patient in clinical trial evaluating a next-generation treatment for aggressive large B-cell lymphoma
April 20, 2026
·
4 min read
Drug Development
BioLineRx Announces Clinical Trial Agreement with St. Jude Children’s Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
BioLineRx Ltd. today announced a multi-center Phase 1 clinical trial sponsored by St. Jude Children’s Research Hospital, Inc. to evaluate motixafortide for the mobilization of CD34+ hematopoietic stem cells (HSCs) used in the development of gene therapies for patients with sickle cell disease (SCD).
May 30, 2024
·
8 min read
Press Releases
Enpro to Present at Oppenheimer 21st Annual Industrial Growth Conference
April 30, 2026
·
1 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Highlights Execution Momentum and Expanding AI Pipeline Following Strategic Growth Initiative
April 24, 2026
·
2 min read
Press Releases
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
April 30, 2026
·
2 min read
Press Releases
Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma
May 21, 2026
·
7 min read
1 of 84,570
Next
